{"title":"Effectiveness of Kirschner wire versus clavicular hook plate fixation in the treatment of distal clavicle fractures in children.","authors":"Chun Hong, Weisheng Shi","doi":"10.62347/HMWD1196","DOIUrl":"https://doi.org/10.62347/HMWD1196","url":null,"abstract":"<p><strong>Purpose: </strong>To compare the treatment results of Kirschner wire (K-wire) fixation and clavicular hook plate (CHP) fixation for pediatric distal clavicle fractures, and to investigate the influence of age and fracture type on treatment selection.</p><p><strong>Method: </strong>This retrospective study analyzed data from 136 children with distal clavicular fractures treated between January 2020 and December 2023, divided into a K-wire group (n = 68) and a CHP group (n = 68) based on the surgical method. Perioperative indicators, radiographic healing quality, shoulder function, quality of life and complications were all observed. Subgroup analyses were performed based on age (≤ 6 years vs. 7-14 years) and fracture type (Neer II vs. Neer IV/V).</p><p><strong>Results: </strong>The K-wire group demonstrated a minimally invasive profile, with significantly shorter operative times and less intraoperative blood loss. At 6 months post-injury, the CHP group showed a larger callus volume, a smaller fracture gap (P < 0.001), and a 0.5-month shorter healing time for Neer IV/V fractures (P = 0.007). The CHP group had significantly higher Constant-Murley scores, greater range of motion in forward flexion/abduction, and lower QuickDASH scores. The CHP group showed superior short-term physical health outcomes. Subgroup analysis showed that K-wires were better for controlling surgical trauma in children aged 6 and below (P < 0.05), and that the CHP group had faster healing and better functional recovery for children aged 7-14 years and Neer IV/V fractures (P < 0.05).</p><p><strong>Conclusion: </strong>K-wire fixation is more suitable for younger children and simple fractures due to its minimally invasive nature; CHP fixation is highly effective in promoting fracture healing and functional recovery of complex fractures in older children, and both techniques demonstrated acceptable safety profiles.</p>","PeriodicalId":7731,"journal":{"name":"American journal of translational research","volume":"18 9","pages":"8212-8226"},"PeriodicalIF":1.8,"publicationDate":"2026-09-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13687845/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149260364","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Effect of Hashimoto's thyroiditis background on the diagnostic performance of deep fusion ultrasound elastography for benign and malignant thyroid nodules.","authors":"Ziying Yang, Xin Zhou, Shuchong Peng, Zhaoliang Fu, Xiaoqun Deng, Li Shen","doi":"10.62347/LPWZ3858","DOIUrl":"https://doi.org/10.62347/LPWZ3858","url":null,"abstract":"<p><strong>Objective: </strong>To investigate the effect of Hashimoto's thyroiditis (HT) on deep fusion ultrasound elastography in differentiating benign from malignant thyroid nodules, and to evaluate the predictive value of elastographic data and ultrasound features.</p><p><strong>Methods: </strong>A retrospective analysis was conducted on 362 thyroid nodules (from 328 patients, Jan 2021-Jun 2024), which were divided into training (253) and validation (109) cohorts at a 7:3 ratio. The training set comprised 113 nodules from HT patients and 140 nodules from non-HT patients. Conventional ultrasound and deep fusion elastography were performed. Diagnostic performance was compared against pathology, independent risk factors were identified by logistic regression, and a nomogram was constructed and validated using ROC curves.</p><p><strong>Results: </strong>Baseline characteristics were balanced (<i>P</i>>0.05). HT nodules exhibited significantly higher rates of abundant blood flow and ill-defined margins, along with higher elasticity scores (ES), strain ratios (SR), and a higher proportion of microcalcifications (<i>P</i><0.001). The specificity, accuracy, and positive predictive values of elastography were significantly lower in the HT group (<i>P</i><0.05), while sensitivity and negative predictive value were similar. ES ≥4.5, SR ≥3.635, abundant intranodular blood flow, and ill-defined margins were independent malignancy predictors. The combined four-indicator model outperformed any single indicator, and the nomogram demonstrated satisfactory diagnostic performance.</p><p><strong>Conclusion: </strong>Concurrent HT reduces the specificity, accuracy, and positive predictive value of deep fusion elastography. Combining ES, SR, blood flow, and margin features effectively improves differential diagnosis of thyroid nodules in HT patients.</p>","PeriodicalId":7731,"journal":{"name":"American journal of translational research","volume":"18 9","pages":"8470-8480"},"PeriodicalIF":1.8,"publicationDate":"2026-09-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13687876/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149260459","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"PEGylated gambogenic acid nanostructured lipid carriers enhance intracellular delivery in A549 cells via clathrin-, caveolae-mediated endocytosis and macropinocytosis.","authors":"Bian Zhang, Qiongfang Yu, Jiali Chang, Weidong Chen","doi":"10.62347/XCQG1012","DOIUrl":"https://doi.org/10.62347/XCQG1012","url":null,"abstract":"<p><strong>Objective: </strong>To investigate the transport mechanism of gambogenic acid (GNA) and PEGylated gambogenic acid nanostructured lipid carriers (P-GNA-NLC) in A549 cells and to quantify their intracellular contents.</p><p><strong>Methods: </strong>The GNA content in A549 cells was determined by high-performance liquid chromatography (HPLC). The mechanisms of GNA and P-GNA-NLC entry were elucidated using various experimental conditions, including different temperatures, concentrations, times, and endocytosis inhibitors. Initially, A549 cells were obtained through cell culture, and HPLC was employed to establish the quantitative analysis of GNA inside the cells. Subsequent experimentation involved the determination of cellular uptake profiles, the execution of carrier saturation experiments, investigations into the effects of varying temperatures and concentrations on uptake efficiency, and the implementation of endocytosis inhibitor treatment experiments. In the latter, the inhibitor's potential for inducing cellular toxicity was determined by means of an MTT assay, and the inhibitor concentration that exhibited minimal effect on cellular activity was selected for subsequent experimentation.</p><p><strong>Results: </strong>Both GNA and P-GNA-NLC entered A549 cells via active transport. GNA entered mainly through caveolae-mediated endocytosis (Cav-ME) and macropinocytosis, whereas P-GNA-NLC could enter the cells through clathrin-dependent endocytosis (CDE) pathway in addition to Cav-ME and macropinocytosis. This may account for the stronger antitumor effect of P-GNA-NLC than GNA. Furthermore, the entry of P-GNA-NLC into cells in the form of nanolipid carriers may have improved the intracellular pharmacokinetics of GNA, thus enhancing the efficacy of GNA.</p><p><strong>Conclusion: </strong>P-GNA-NLC enters cells via the Cav-ME, macropinocytosis, and CDE pathways. These findings provide a preliminary understanding of the intracellular transport mechanisms of GNA and P-GNA-NLC and provide an experimental basis for the clinical application of GNA antitumor drugs.</p>","PeriodicalId":7731,"journal":{"name":"American journal of translational research","volume":"18 9","pages":"7634-7644"},"PeriodicalIF":1.8,"publicationDate":"2026-09-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13687747/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149260572","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Neutrophil-to-lymphocyte ratio combined with serum albumin predicts catheter removal in patients with peritoneal dialysis-associated peritonitis: a retrospective cohort study of 156 cases.","authors":"Hongxia Peng, Kai Pan, Yufan Ye","doi":"10.62347/GHMN7749","DOIUrl":"https://doi.org/10.62347/GHMN7749","url":null,"abstract":"<p><strong>Objectives: </strong>Peritoneal dialysis-associated peritonitis (PDAP) can lead to catheter removal, but early risk stratification remains difficult. We evaluated whether neutrophil-to-lymphocyte ratio (NLR), combined with serum albumin, identifies patients at increased risk of catheter removal.</p><p><strong>Methods: </strong>This retrospective cohort included 156 patients with PDAP treated from August 2022 to July 2025. Baseline clinical, laboratory, microbiological, and outcome data were extracted from medical records. Blood samples were obtained within 24 hours after PDAP onset. Logistic regression, receiver operating characteristic analysis, restricted cubic spline analysis, bootstrap validation, and decision curve analysis were used to assess the NLR-albumin model.</p><p><strong>Results: </strong>Catheter removal occurred in 35 patients. These patients had higher NLR and lower serum albumin than those with catheter retention. In the multivariable model using the enter method, NLR was positively associated with catheter removal, whereas serum albumin was inversely associated with this outcome. The combined NLR-albumin model performed better than either marker alone and retained acceptable discrimination and calibration after 1,000 bootstrap resamples. Restricted cubic spline analysis suggested a threshold pattern for NLR and an approximately linear inverse association for serum albumin.</p><p><strong>Conclusions: </strong>Baseline NLR and serum albumin may support early risk stratification in PDAP. The combined model was internally validated but requires external validation before clinical use.</p>","PeriodicalId":7731,"journal":{"name":"American journal of translational research","volume":"18 9","pages":"7919-7934"},"PeriodicalIF":1.8,"publicationDate":"2026-09-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13687745/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149260606","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Risk factor for impaired lung function in asthmatic children: predictive value of 25-OH-D, BMI and inflammatory markers.","authors":"Yale Zhang, Xiaoquan Liu, Weihua Zhang, Ying Wang, Congni Qi, Mingbo Zhang, Ming Lv","doi":"10.62347/KKJG5734","DOIUrl":"https://doi.org/10.62347/KKJG5734","url":null,"abstract":"<p><strong>Objective: </strong>This cross-sectional study investigated the associations between modifiable metabolic risk factors (vitamin D status and obesity) and pulmonary function decline in children with asthma, independent of disease duration and airway inflammation.</p><p><strong>Methods: </strong>Medical records of 430 asthmatic children (aged ≤14 years) were retrospectively analyzed. Using FEV1%pred <80% as the cutoff, 171 children with pulmonary function impairment were compared with 259 children with normal pulmonary function. Clinical characteristics, pulmonary function parameters, and laboratory indices (25-(OH)-D, BMI, CRP, IL-6, TNF-α) were collected. Multivariate logistic regression and receiver operating characteristic (ROC) analyses were performed.</p><p><strong>Results: </strong>Among the 430 enrolled children, 171 (39.75%) presented with pulmonary function impairment, predominantly of mild-to-moderate severity. Compared with children with normal pulmonary function, those with impaired pulmonary function had longer disease duration, lower ACT scores, decreased 25-(OH)-D levels, and elevated BMI, CRP, IL-6, and TNF-α levels (all P<0.05). 25-(OH)-D levels were positively correlated with FEV1%pred and FEV1/FVC, and negatively correlated with BMI, CRP, IL-6, and TNF-α (all P<0.001). Multivariate logistic regression analysis identified prolonged disease duration (OR=1.789, 95% CI: 1.333-2.401), elevated BMI (OR=1.205, 95% CI: 1.035-1.403), increased IL-6 (OR=1.193, 95% CI: 1.086-1.312), elevated CRP (OR=1.362, 95% CI: 1.118-1.658), and secondhand smoke exposure (OR=3.336, 95% CI: 1.567-7.102) as independent risk factors for pulmonary function impairment (all P<0.05). Conversely, higher ACT scores (OR=0.763, 95% CI: 0.675-0.861) and 25-(OH)-D levels (OR=0.818, 95% CI: 0.730-0.916) were associated with a lower likelihood of pulmonary function impairment (all P<0.01). Ten-fold cross-validated ROC analysis demonstrated that the mean AUC values of 25-(OH)-D, BMI, IL-6, CRP, and TNF-α were 0.883, 0.806, 0.862, 0.845, and 0.827, respectively.</p><p><strong>Conclusion: </strong>Vitamin D status and secondhand smoke exposure were significantly associated with pulmonary function impairment in children with asthma. Our findings suggest a metabolic component in childhood asthma, although causal inference is limited by the cross-sectional design. Prospective studies are warranted to validate these associations and further clarify underlying mechanisms.</p>","PeriodicalId":7731,"journal":{"name":"American journal of translational research","volume":"18 9","pages":"7799-7809"},"PeriodicalIF":1.8,"publicationDate":"2026-09-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13687695/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149260690","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Ultrasonic debridement promotes wound healing and enhances infection control compared with surgical debridement in diabetic foot ulcers: a propensity score-matched retrospective study.","authors":"Deheng Song, Hanming Chen, Dan Shao","doi":"10.62347/MHUW5597","DOIUrl":"https://doi.org/10.62347/MHUW5597","url":null,"abstract":"<p><strong>Objective: </strong>To compare wound healing rates, infection control, tissue perfusion, and quality-of-life outcomes between low-frequency ultrasonic debridement (UD) and surgical debridement in patients with diabetic foot ulcers (DFUs).</p><p><strong>Methods: </strong>This single-center, retrospective study included 298 DFU patients treated in the Department of Burns and Plastic Surgery at the Central Hospital of Xuzhou from January 2021 to January 2025. Patients were grouped by the first documented debridement method: UD (n=142) or surgical debridement (n=156). Propensity score matching (PSM) at a 1:1 ratio was used to balance baseline confounders, resulting in 230 patients (115 per group). The primary outcome was the 12-week complete healing rate. Secondary outcomes included healing time, wound area reduction, infection control rate, antibiotic use, transcutaneous oxygen pressure (TcPO<sub>2</sub>) changes, Wollina Wound Score, safety, and the 36-Item Short Form Health Survey (SF-36) scores.</p><p><strong>Results: </strong>After PSM, baseline characteristics were well balanced. The 12-week healing rate was significantly higher in the UD group than in the surgical debridement group (67.8% vs. 53.9%; P<0.05). Median healing time was significantly shorter in the UD group (15.3 weeks vs. 21.6 weeks; log-rank P=0.003). UD was associated with a greater wound area reduction (81.4% ± 20.7% vs. 70.3% ± 24.5%; P<0.05) and a higher infection control rate (75.7% vs. 60.9%; P<0.05). The cumulative antibiotic days were fewer in the UD group (median 21.0 vs. 28.0 days; P<0.05). Improvements in TcPO<sub>2</sub> and Wollina Wound Score were significantly greater with UD (P<0.001). The SF-36 physical and mental component summary scores improved more in the UD group (both P<0.001). Rates of major amputation and overall adverse events did not differ significantly between the two groups.</p><p><strong>Conclusion: </strong>Weekly low-frequency UD was associated with improved healing, infection control, tissue perfusion, and quality of life compared with surgical debridement in DFU patients, with a comparable safety profile.</p>","PeriodicalId":7731,"journal":{"name":"American journal of translational research","volume":"18 9","pages":"8159-8170"},"PeriodicalIF":1.8,"publicationDate":"2026-09-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13687858/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149260764","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Video laryngoscope-guided double-lumen tube tracheal intubation in the left-lateral position for thoracoscopic surgery: an open-label randomized non-inferiority trial.","authors":"Zhouting Hu, Kai Li, Xi Zhang","doi":"10.62347/CCWB1159","DOIUrl":"https://doi.org/10.62347/CCWB1159","url":null,"abstract":"<p><strong>Objective: </strong>To evaluate whether double-lumen tube (DLT) intubation guided by video laryngoscope in the left-lateral position is superior to that in the supine position.</p><p><strong>Methods: </strong>A prospective, single-center, open-label, randomized, non-inferiority trial included 94 patients (aged 18-75 years) undergoing thoracoscopic right lung surgery in the left position from July 2022 to September 2025. Patients were randomized to receive DLT intubation in the lateral or supine position. The primary outcome was total intubation time (TNI), with a non-inferiority margin (δ) of 10s. Secondary outcomes included first-attempt intubation success, Cormack-Lehane score, number of DLT adjustments, preparation time for patient positioning, number of medical staff required for positioning, and number of facilitating maneuvers. Safety outcomes were also recorded.</p><p><strong>Results: </strong>All patients were successfully intubated on the first attempt. TNI in the lateral position was 7 s (97.5% CI, 3 to 10) longer than that in the supine position. Compared with the supine group, the lateral group required fewer intubation adjustments, had a shorter preparation time for postural placement, had fewer medical staff personnel for postural placement, and intubation misplacement of the DLT was more common in the lateral group (<i>P</i> = 0.006). Furthermore, serial postoperative assessment revealed that airway discomfort (measured by NRS) peaked at 6 hours after extubation in both groups. Comprehensive clinical evaluation demonstrated that the lateral position significantly reduced the airway management difficulty score, while maintaining a comparable procedure smoothness index, confirming its clinical efficiency and feasibility.</p><p><strong>Conclusion: </strong>Video laryngoscope-guided DLT intubation in the left lateral position was non-inferior to the supine position in terms of operational feasibility.</p>","PeriodicalId":7731,"journal":{"name":"American journal of translational research","volume":"18 9","pages":"8364-8375"},"PeriodicalIF":1.8,"publicationDate":"2026-09-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13687869/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149260847","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"SGLT-2 inhibitor dapagliflozin improves left ventricular diastolic function and reduces circulating inflammatory markers in HFpEF patients: a retrospective cohort study.","authors":"Jian-Feng Ye, Jian Zhang, Xu Wang, Guang-Quan Yang, Min-Fang Yao, Wei Liu, Lin-Lin Pei","doi":"10.62347/RELO8745","DOIUrl":"https://doi.org/10.62347/RELO8745","url":null,"abstract":"<p><strong>Objective: </strong>This study sought to evaluate the efficacy of sodium-glucose cotransporter 2 (SGLT-2) inhibitor Dapagliflozin in ameliorating left ventricular diastolic function (LVDF) and attenuating systemic inflammatory biomarkers in patients with heart failure with preserved ejection fraction (HFpEF).</p><p><strong>Methods: </strong>A total of 114 patients diagnosed with HFpEF were retrospectively enrolled and allocated into either the SGLT-2 inhibitor group (Dapagliflozin combined with standard guideline-directed therapy; n = 58) or the Control group (standard guideline-directed therapy alone; n = 56). Echocardiographic parameters at baseline and 6-month follow-up were measured, including early diastolic transmitral flow velocity/early diastolic mitral annular velocity ratio (E/e') and left atrial volume index (LAVI). Circulating inflammatory markers comprising high-sensitivity C-reactive protein (hs-CRP), interleukin-6 (IL-6), and tumor necrosis factor-alpha (TNF-α) were examined. In addition, N-terminal pro-B-type natriuretic peptide (NT-proBNP) levels and Minnesota Living with Heart Failure Questionnaire (MLHFQ) scores were collected for functional and symptomatic assessments.</p><p><strong>Results: </strong>After six months of treatment, the SGLT-2 inhibitor group exhibited significant improvements in cardiac diastolic parameters. E/e' ratio decreased significantly from 14.8 ± 3.2 to 12.1 ± 2.7 (P < 0.001), and LAVI decreased from 38.6 ± 8.4 to 34.2 ± 7.1 mL/m<sup>2</sup> (P = 0.003). Consistently, systemic inflammation was markedly alleviated. hs-CRP decreased from 4.82 ± 1.73 to 2.94 ± 1.28 mg/L (P < 0.001), IL-6 decreased from 8.46 ± 2.91 to 5.73 ± 2.14 pg/mL (P = 0.002), and TNF-α decreased from 12.8 ± 4.6 to 9.4 ± 3.8 pg/mL (P = 0.011). Moreover, NT-proBNP levels in the SGLT-2 inhibitor group exhibited a substantial 28.4% reduction, which was significantly greater than the 8.7% reduction observed in the Control group (P = 0.004). There was also a striking reduction in MLHFQ scores in the SGLT-2 inhibitor group (average reduction: -8.6 ± 4.2 points, P < 0.001), demonstrating significant symptomatic improvement.</p><p><strong>Conclusion: </strong>SGLT-2 inhibitor Dapagliflozin effectively improved LVDF and reduced systemic inflammatory burden in patients with HFpEF. These findings support the role of Dapagliflozin as a promising disease-modifying therapeutic agent for HFpEF.</p>","PeriodicalId":7731,"journal":{"name":"American journal of translational research","volume":"18 9","pages":"7686-7699"},"PeriodicalIF":1.8,"publicationDate":"2026-09-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13687774/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149260856","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Effects of topical vitamin C compound powder on healing time and pain relief in oral ulcers.","authors":"Lijuan Ling, Xinhua Wang, Peng Chen, Yu Wang","doi":"10.62347/PHBH9020","DOIUrl":"https://doi.org/10.62347/PHBH9020","url":null,"abstract":"<p><strong>Aims: </strong>To evaluate the clinical efficacy and safety of topical vitamin C compound powder in patients with oral ulcers, with a particular focus on its effects on ulcer healing time, pain relief, short-term clinical response, and patient-reported recovery outcomes.</p><p><strong>Methods: </strong>In this retrospective observational study, 300 patients diagnosed with oral ulcers were enrolled. They were divided according to routine clinical treatment regimens: 145 patients received local normal saline treatment alone (control group), and 155 patients received topical vitamin C compound powder combined with identical saline-based basic care (observation group). Primary endpoints included time to pain relief, burning relief, resumption of normal oral intake, complete healing, and complete healing rates at day 5 and day 7. Secondary endpoints comprised longitudinal symptom changes, overall clinical effectiveness, safety and tolerability, patient-reported outcomes, short-term ulcer recurrence, and hospital revisit rates. Multivariable logistic and Cox regression analyses were performed to identify independent prognostic factors for ulcer healing.</p><p><strong>Results: </strong>Compared with the control group, the observation group showed significantly shorter times to pain relief, burning relief, dietary recovery and complete ulcer healing (all P < 0.001), accompanied by elevated 5-day and 7-day complete healing rates and a lower proportion of unhealed lesions on day 7 (all P < 0.001). Although visual analogue scale (VAS) pain scores, burning sensation scores and eating interference scores declined progressively in both groups, the observation group exhibited superior symptom amelioration on day 3, 5, and 7 (all P < 0.001). The 7-day overall therapeutic effective rate was markedly higher in the observation group (89.0% vs. 62.8%, P < 0.001). Additionally, patients in the observation group reported higher treatment satisfaction, better quality-of-life improvement and stronger willingness to reuse the intervention (all P < 0.001). Multivariable regression verified that topical vitamin C compound powder treatment was an independent protective factor for 7-day complete ulcer healing (adjusted OR = 0.118; 95% CI: 0.048-0.289; P < 0.001) and accelerated wound healing (HR = 1.549; 95% CI: 1.302-1.775; P < 0.001).</p><p><strong>Conclusion: </strong>Topical vitamin C compound powder significantly accelerated oral ulcer healing, enhanced pain relief, and improved short-term patient-reported recovery outcomes, with favorable clinical safety and tolerability.</p>","PeriodicalId":7731,"journal":{"name":"American journal of translational research","volume":"18 9","pages":"7775-7786"},"PeriodicalIF":1.8,"publicationDate":"2026-09-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13687744/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149260586","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Efficacy and safety of postoperative chemotherapy with capecitabine and oxaliplatin for advanced gastric cancer.","authors":"Jingjing Wang, Yuge Li, Hao Wang, Xinfu Cai","doi":"10.62347/HPZL4834","DOIUrl":"https://doi.org/10.62347/HPZL4834","url":null,"abstract":"<p><p>This retrospective study aimed to evaluate the efficacy and safety of postoperative chemotherapy with capecitabine (CAP) combined with oxaliplatin (OXA) in patients with advanced gastric cancer (AGC). A total of 90 AGC patients who received treatment at our center between January 2022 and January 2025 were enrolled. Among them, 47 patients who received CAP plus OXA (XELOX regimen) were assigned as the observation group, and the other 43 patients who received epirubicin, cisplatin, and fluorouracil (ECF regimen) were assigned as the control group. The evaluated criteria included therapeutic efficacy, safety profiles (hyperpigmentation, hepatic and renal dysfunction, alopecia, gastrointestinal reaction, and myelosuppression), serum tumor markers (carbohydrate antigen 199 [CA199], carcinoembryonic antigen [CEA], alpha-fetoprotein [AFP]), humoral immunity (immunoglobulin [Ig] A/M/G), gastric hormones (motilin [MTL], gastrin [GAS]), 1-year postoperative recurrence and survival rates, and quality of life (European Organization for Research and Treatment of Cancer Quality of Life Questionnaire Core 30 [EORTC QLQ-C30]). Compared to the control group, the observation group showed a significantly higher overall response rate (P=0.022), lower incidences of myelosuppression (P=0.025) and gastrointestinal reactions (P=0.010), and a higher incidence of peripheral neurotoxicity (P=0.028). Additionally, the post-treatment levels of serum tumor markers were significantly reduced in the observation group (P<0.05), whereas humoral immune indices and gastric hormones levels were significantly increased (P<0.05). The 1-year survival rate was also significantly higher in the observation group (P=0.028). After Bonferroni correction for multiple comparisons, the observation group demonstrated superior outcomes in CA199, MTL, GAS, physical functioning, nausea and vomiting, and pain compared to the control group (adjusted P<0.00294 for all). These findings suggest that the CAP-OXA combination may provide improved therapeutic efficacy and acceptable safety in postoperative chemotherapy for AGC patients.</p>","PeriodicalId":7731,"journal":{"name":"American journal of translational research","volume":"18 9","pages":"8088-8098"},"PeriodicalIF":1.8,"publicationDate":"2026-09-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13687841/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149260601","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}